Advertisement
Advertisement
IMDX
I
Insight Molecular Diagnostics Inc. Common Stock
4.34
USDSponsored
+0.20
+4.83%
Mar 26, 10:52 UTC -4
Open
IMDX Earnings Reports
Positive Surprise Ratio
IMDX beat 15 of 40 last estimates.
38%
Next Report
Today AMC
Date of Next Report
Mar 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
$295.80K
/-$0.24
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
-80.09%
/-87.56%
Insight Molecular Diagnostics Inc. Common Stock earnings per share and revenue
On --, IMDX reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 295.80 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
Mar 12, 2026 For Q4 25
Estimate
-Actual
-$0.01
Surprise
-
CareCloud, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.03
Actual
$0.03
Surprise
-15.97%
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
Health Catalyst, Inc Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.09
Actual
$0.08
Surprise
-13.79%
Neuraxis, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.21
Actual
-$0.17
Surprise
+22.48%
Heartflow, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.12
Surprise
+30.31%
Heartbeam, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.14
Surprise
-0.72%
HeartSciences Inc. Common Stock
Report Date
Mar 16, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.63
Surprise
+27.34%
FAQ
What were Insight Molecular Diagnostics Inc. Common Stock's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Insight Molecular Diagnostics Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Insight Molecular Diagnostics Inc. Common Stock's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Insight Molecular Diagnostics Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 26, 2026.
What are the forecasts for Insight Molecular Diagnostics Inc. Common Stock's next earnings report?
Based on 6
analysts, Insight Molecular Diagnostics Inc. Common Stock is expected to report EPS of -$0.24 and revenue of $295.80K for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement